Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-19
2011-04-19
Richter, Johann R (Department: 1627)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S393000
Reexamination Certificate
active
07928117
ABSTRACT:
Pharmaceutical formulations and methods including an immune response modifier (IRM) compound and an oleic acid component are provided where stability is improved by using oleic acid have low polar impurities such as peroxides.
REFERENCES:
patent: RE24906 (1960-12-01), Ulrich
patent: 3700674 (1972-10-01), Diehl et al.
patent: 4013665 (1977-03-01), Crenshaw et al.
patent: 4052393 (1977-10-01), Treuner
patent: 4191767 (1980-03-01), Warner, Jr. et al.
patent: 4197403 (1980-04-01), Warner, Jr. et al.
patent: 4411893 (1983-10-01), Johnson et al.
patent: 4601856 (1986-07-01), Suzuki et al.
patent: 4686125 (1987-08-01), Johnston et al.
patent: 4689338 (1987-08-01), Gerster
patent: 4695465 (1987-09-01), Kigasawa et al.
patent: 4698348 (1987-10-01), Gerster
patent: 4722941 (1988-02-01), Eckert et al.
patent: 4746515 (1988-05-01), Cheng et al.
patent: 4751087 (1988-06-01), Wick
patent: 4863970 (1989-09-01), Patel et al.
patent: 4908389 (1990-03-01), Mahjour et al.
patent: 4929624 (1990-05-01), Gerster et al.
patent: 5008110 (1991-04-01), Benecke et al.
patent: 5238944 (1993-08-01), Wick et al.
patent: 5266575 (1993-11-01), Gerster et al.
patent: 5268376 (1993-12-01), Gester
patent: 5300291 (1994-04-01), Sablotsky et al.
patent: 5346905 (1994-09-01), Gerster
patent: 5352784 (1994-10-01), Nikolaides et al.
patent: 5389640 (1995-02-01), Gerster et al.
patent: 5446153 (1995-08-01), Lindstrom et al.
patent: 5472982 (1995-12-01), Suzuki
patent: 5482936 (1996-01-01), Lindstrom
patent: 5532030 (1996-07-01), Hirose et al.
patent: 5736553 (1998-04-01), Wick et al.
patent: 5756747 (1998-05-01), Gerster
patent: 5919815 (1999-07-01), Bradley et al.
patent: 5939090 (1999-08-01), Beaurline et al.
patent: 6039969 (2000-03-01), Tomai et al.
patent: 6103697 (2000-08-01), Bergstrand et al.
patent: 6110929 (2000-08-01), Gerster et al.
patent: 6194425 (2001-02-01), Gerster et al.
patent: 6200592 (2001-03-01), Tomai et al.
patent: 6210712 (2001-04-01), Edgren et al.
patent: 6245776 (2001-06-01), Skwierczynski et al.
patent: 6267957 (2001-07-01), Green et al.
patent: 6331539 (2001-12-01), Crooks et al.
patent: 6376669 (2002-04-01), Rice et al.
patent: 6425776 (2002-07-01), Fredl et al.
patent: 6451810 (2002-09-01), Coleman et al.
patent: 6498261 (2002-12-01), Ewbank et al.
patent: 6525064 (2003-02-01), Dellaria et al.
patent: 6541485 (2003-04-01), Crooks et al.
patent: 6545016 (2003-04-01), Dellaria et al.
patent: 6545017 (2003-04-01), Dellaria et al.
patent: 6559182 (2003-05-01), Purcell
patent: 6562363 (2003-05-01), Mantelle et al.
patent: 6573273 (2003-06-01), Crooks et al.
patent: 6638528 (2003-10-01), Kanios
patent: 6656938 (2003-12-01), Crooks et al.
patent: 6660735 (2003-12-01), Crooks et al.
patent: 6660747 (2003-12-01), Crooks et al.
patent: 6664260 (2003-12-01), Charles et al.
patent: 6664264 (2003-12-01), Dellaria et al.
patent: 6664265 (2003-12-01), Crooks et al.
patent: 6667312 (2003-12-01), Bonk et al.
patent: 6670372 (2003-12-01), Charles et al.
patent: 6677347 (2004-01-01), Crooks et al.
patent: 6677348 (2004-01-01), Heppner et al.
patent: 6677349 (2004-01-01), Griesgraber
patent: 6683088 (2004-01-01), Crooks et al.
patent: 6756382 (2004-06-01), Coleman et al.
patent: 6797718 (2004-09-01), Dellaria et al.
patent: 6803420 (2004-10-01), Cleary et al.
patent: 6818650 (2004-11-01), Griesgraber
patent: 7056528 (2006-06-01), Bracht et al.
patent: 7504114 (2009-03-01), Kurita et al.
patent: 2002/0128345 (2002-09-01), Paul
patent: 2003/0026794 (2003-02-01), Fein
patent: 2003/0059471 (2003-03-01), Compton et al.
patent: 2003/0072814 (2003-04-01), Maibach et al.
patent: 2003/0096012 (2003-05-01), Besse et al.
patent: 2003/0124191 (2003-07-01), Besse et al.
patent: 2003/0170308 (2003-09-01), Cleary et al.
patent: 2003/0199538 (2003-10-01), Skwierczynski
patent: 2003/0211163 (2003-11-01), Chong
patent: 2004/0089855 (2004-05-01), Oommen et al.
patent: 2004/0091491 (2004-05-01), Kedl et al.
patent: 2004/0132766 (2004-07-01), Griesgraber
patent: 2004/0147543 (2004-07-01), Hays et al.
patent: 2004/0176367 (2004-09-01), Griesgraber et al.
patent: 2004/0192585 (2004-09-01), Owens et al.
patent: 2004/0242770 (2004-12-01), Feldstein et al.
patent: 2005/0037030 (2005-02-01), Kumar et al.
patent: 2005/0175630 (2005-08-01), Raz et al.
patent: 2005/0201959 (2005-09-01), David
patent: 2005/0276842 (2005-12-01), Zhang et al.
patent: 2005/0281772 (2005-12-01), Bromley et al.
patent: 2006/0024243 (2006-02-01), Arkin et al.
patent: 2006/0034779 (2006-02-01), Arkin et al.
patent: 2006/0039931 (2006-02-01), Scheiwe et al.
patent: 2007/0167479 (2007-07-01), Busch et al.
patent: 0 107 455 (1984-05-01), None
patent: 0 187 705 (1986-07-01), None
patent: 0 394 026 (1990-10-01), None
patent: 0 582 581 (1999-05-01), None
patent: 1 512 685 (2006-07-01), None
patent: P0002103-AB (2000-10-01), None
patent: 61-00297 A (1986-01-01), None
patent: 62-148449 A (1987-07-01), None
patent: 05-246948 A (1993-09-01), None
patent: 07-138145 A (1995-05-01), None
patent: 76145 (1983-02-01), None
patent: 76045 (1995-12-01), None
patent: WO 88/09676 (1988-12-01), None
patent: WO 92/15582 (1992-09-01), None
patent: WO-01/06829 (2001-02-01), None
patent: WO-01/07009 (2001-02-01), None
patent: WO-2004/024126 (2004-03-01), None
patent: WO-2004/037201 (2004-05-01), None
patent: WO-2005/020995 (2005-03-01), None
patent: WO-2005/020999 (2005-03-01), None
patent: WO-2005/067897 (2005-07-01), None
patent: WO-2005/074894 (2005-08-01), None
patent: WO-2005/079143 (2005-09-01), None
patent: WO-2005/089317 (2005-09-01), None
patent: WO 2006/074046 (2006-07-01), None
patent: WO 2008/010963 (2008-01-01), None
Feb. 23, 2010 Complaint with supporting documents;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-00937 (WJM-MF).
Feb. 28, 2010 Nordsiek Declaration with Exhibits A & B;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-00937(WJM-MF).
Feb. 28, 2010 Nordsiek Exhibit D;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-00937(WJM-MF).
Feb. 28, 2010 Novak Exhibit 6;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-00937(WJM-MF).
Feb. 28, 2010 Novak Exhibits 7-8;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-00937(WJM-MF).
Feb. 28, 2010 Novak Exhibits 9-10;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-00937(WJM-MF).
Feb. 28, 2010 TRO Brief;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-00937(WJM-MF).
Mar. 1, 2010 Redacted Memorandum in Opposition;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-937 (WJM-MF).
Mar. 1, 2010 Banker Declaration;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-00937 (WJM-MF).
Mar. 1, 2010 Colucci Declaration;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-00937 (WJM-MF).
Mar. 1, 2010 Palmieri Declaration;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-00937 (WJM-MF).
Mar. 1, 2010 Romito Declaration;Graceway Pharmaceuticals, LLC and 3M Innovative Properties Companyv.Perrigo Company et al., U.S. District Court, District of New Jersey, Case No. 2:10-cv-00937 (WJM-MF).
Mar. 2, 2010 Hearing Transcr
Nelson Robert J.
Statham Alexis S.
3M Innovative Properties Company
Edwards Angell Palmer & & Dodge LLP
Manso Peter J.
McMillian Kara R
Richter Johann R
LandOfFree
Method of inducing cytokine biosynthesis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of inducing cytokine biosynthesis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of inducing cytokine biosynthesis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2734144